Reuters logo
BRIEF-Juno CEO says second patient also dies in leukemia trial: Conf Call
2016年11月23日 / 下午2点22分 / 1 年前

BRIEF-Juno CEO says second patient also dies in leukemia trial: Conf Call

Nov 23 (Reuters) - Juno Therapeutics Inc

* Juno CEO says second patient with cerebral edema also dies in leukemia trial, called rocket, testing JCAR015: Conf Call

* Juno execs say they are not sure whether or not to discontinue the trial, still looking at data : Conf Call

* Juno says patient deaths unrelated to manufacturing process: Conf Call

* Juno CEO says removal of chemotherapy fludarabine has contributed to lower toxicity, but “hasn’t taken us as far as we hoped it would” : Conf Call Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below